Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?

G Milne, T Hames, C Scotton, N Gent… - The Lancet …, 2021 - thelancet.com
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”

BL Sievers, MTK Cheng, K Csiba, B Meng… - Cellular & Molecular …, 2024 - nature.com
An ancient conflict between hosts and pathogens has driven the innate and adaptive arms of
immunity. Knowledge about this interplay can not only help us identify biological …

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

S Kakavandi, I Zare, M VaezJalali, M Dadashi… - Cell Communication and …, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is caused by a new member of the
Coronaviridae family known as severe acute respiratory syndrome coronavirus 2 (SARS …

Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8

X Wu, T **a, WJ Shin, KM Yu, W Jung, A Herrmann… - MBio, 2022 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers cytokine-
mediated inflammation, leading to a myriad of clinical presentations in COVID-19. The SARS …

SARS-CoV-2 ORF8: One protein, seemingly one structure, and many functions

S Vinjamuri, L Li, M Bouvier - Frontiers in immunology, 2022 - frontiersin.org
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. The genome of SARS-
CoV-2 encodes nine accessory proteins that are involved in host-pathogen interaction …

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites

MJ Islam, NN Islam, MS Alom, M Kabir, MA Halim - Immunobiology, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
COVID-19, is a highly transmittable and pathogenic human coronavirus that first emerged in …

SARS-CoV-2 ORF8: a rapidly evolving immune and viral modulator in COVID-19

A Arduini, F Laprise, C Liang - Viruses, 2023 - mdpi.com
The COVID-19 pandemic has resulted in upwards of 6.8 million deaths over the past three
years, and the frequent emergence of variants continues to strain global health. Although …

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2

MMH Sakib, AA Nishat, MT Islam, MAR Uddin… - Computers in biology …, 2021 - Elsevier
The receptor-binding domain (RBD) of SARS-CoV-2 spike (S) protein plays a vital role in
binding and internalization through the alpha-helix (AH) of human angiotensin-converting …

Antiviral face mask functionalized with solidified hand soap: Low-cost infection prevention clothing against enveloped viruses such as SARS-CoV-2

A Cano-Vicent, A Tuñón-Molina, M Martí… - ACS …, 2021 - ACS Publications
Infection prevention clothing is becoming an essential protective tool in the current
pandemic, especially because now we know that severe acute respiratory syndrome …

The importance of accessory protein variants in the pathogenicity of SARS-CoV-2

SS Hassan, PP Choudhury, GW Dayhoff II… - Archives of biochemistry …, 2022 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) is caused by the Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) with an estimated fatality rate of less …